Table 2

Summary of key mass spectrometry fragmentation for delavirdine and its metabolites

Table 2
CompoundMatrixIonization Mode2-aMH+Fragments (m/z)2-b
ABCDEF
DLVPlasma, bile, urineESI4571362-c 3232212472-c , 2-d 3782-c , 2-d
MET-2Bile, urineESI323237
MET-4aUrineAPCI4951792-e 2372072-e
MET-4b,dUrineESI511323275, 1952-e 2212-e
MET-4b,dUrineAPCI5112752373372-e
MET-4cBile, urineESI, APCI6181792-d , 2-f 2372-d
MET-4cUrineCI6183231792-f 2372073372-f
MET-5Plasma, bile, urineESI4151792372-d 2053362-c , 2-d
MET-5UrineCI41595323179207337
MET-6Plasma, urineESI6492372-g 2372632-g 5702-c
MET-6BileESI2-h 6492372-g 2632-g 3942-g
MET-7UrineESI473263
MET-7UrineAPCI473237237263395
MET-12Bile, urineESI221
MET-15b,dUrineAPCI431195237221353
MET-16BileESI2-h 6492212-g 2472-g 3942-g
MET-17BileESI2-h 633499221247553
  • 2-a APCI, atmospheric pressure chemical ionization; CI, chemical ionization; ESI, electrospray ionization.

  • 2-b Some fragments are not observed because of the structure of the compound or because of low concentrations.

  • 2-c Not observed in urine.

  • 2-d Not observed in bile.

  • 2-e Minus sulfate.

  • 2-f Minus N-acetylglucosamine.

  • 2-g Minus glucuronic acid.

  • 2-h Product-ion spectrum.